Evidence map›Paper›PMID 42879013›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2027

Molecular Approaches to Diagnosis in Ewing Sarcoma: Targeted RNA Sequencing.

Carmen Salguero-Aranda, Amparo Beltran-Povea, Juan Diaz-Martin

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Carmen Salguero-ArandaInstituto de Biomedicina de Sevilla, CSIC-Universidad de Sevilla, Department of Pathology, Hospital Universitario Virgen del Rocío, Seville, Spain.
Amparo Beltran-PoveaInstituto de Biomedicina de Sevilla, CSIC-Universidad de Sevilla, Department of Pathology, Hospital Universitario Virgen del Rocío, Seville, Spain.
Juan Diaz-MartinInstituto de Biomedicina de Sevilla, CSIC-Universidad de Sevilla, Department of Pathology, Hospital Universitario Virgen del Rocío, Seville, Spain. jdiaz-ibis@us.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular testing for pathognomonic gene fusions is mandatory for the diagnosis of small round cell tumors. In particular, in Ewing sarcoma, the identification of specific chimeric fusion genes is critical to distinguish it from other histologically similar subtypes. As the clinical relevance of gene fusion detection continues to grow, many laboratories have adopted targeted next-generation sequencing approaches to overcome the limitations of conventional singleplex assays. We were among the early adopters of targeted RNA sequencing using anchored multiplex PCR, a technique that enables the simultaneous detection of multiple fusion transcripts with prior knowledge of only one fusion partner. In this chapter, we provide a detailed description of our workflow, including recommendations for nucleic acid extraction, library preparation, sequencing, and interpretation of gene fusion results.

Indexed as

Bone NeoplasmsHigh-Throughput Nucleotide SequencingSarcoma, EwingSequence Analysis, RNAGene FusionHumansMultiplex Polymerase Chain ReactionOncogene Proteins, FusionOncogene Proteins, FusionAnchored multiplex PCR (AMP)Ewing sarcomaFFPE sampleGene fusionNucleic acid extractionPrecision diagnosticsTargeted RNA-seq

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.